[1] WHO. Global hepatitis report. https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/, 2017, 4.
[2] Wang FZ, Zhang GM, Shen LP, et al. Comparative analyze on hepatitis B seroepidemiological surveys among population aged 1-29 years in different epidemic regions of China in 1992 and 2014. Chin J Prev Med, 2017; 51, 462. (In Chinese)
[3] Anh NT. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016:a modelling study. Lancet Gastroenterol Hepatol, 2018; 3, 383-403. doi:  10.1016/S2468-1253(18)30056-6
[4] Bai X, Yang H, Wan L, et al. Involvement of viperin in prevention of intrauterine transmission of hepatitis B virus. APMIS, 2017; 125, 170-5. doi:  10.1111/apm.2017.125.issue-2
[5] Xu YY, Liu HH, Zhong YW, et al. Peripheral Blood Mononuclear Cell Traffic Plays a Crucial Role in Mother-to-Infant Transmission of Hepatitis B Virus. Int J Biol Sci, 2015; 11, 266-73. doi:  10.7150/ijbs.10813
[6] Wang XJ, Wang SP, Li TG, et al. Relationship between PBMC transportation and hepatitis B virus intrauterine transmission. Chin J Publ Heal, 2007; 23, 571-2. (In Chinese) http://d.old.wanfangdata.com.cn/Periodical/zgggws200705027
[7] Bai GQ, Li SH. The study on role of peripheral blood mononuclear cell in HBV intrauterine infection. Arch Gynecol Obstet, 2011; 283, 317. doi:  10.1007/s00404-010-1366-8
[8] Lanford RE, Michaels MG, Chavez D, et al. Persistence of extrahepatic hepatitis B virus DNA in the absence of detectable hepatic replication in patients with baboon liver transplants. J Med Virol, 2010; 46, 207-12.
[9] Shi XH, Wang SP, Li SZ, et al. Study on replication status of HBsAg positive pregnant women and newborns. Chin J Publ Heal, 2004; 20, 513-4. (In Chinese)
[10] Joshi SS, Coffin CS. Hepatitis B virus lymphotropism:emerging details and challenges. Biotechnol Genet Eng Rev, 2018; 1-13. http://d.old.wanfangdata.com.cn/NSTLQK/NSTL_QKJJ024576485/
[11] Stoll-Becker S, Repp R, Glebe D, et al. Transcription of hepatitis B virus in peripheral blood mononuclear cells from persistently infected patients. J Virol, 1997; 71, 5399-407. http://d.old.wanfangdata.com.cn/OAPaper/oai_pubmedcentral.nih.gov_191779
[12] Coffin CS, Mulrooney-Cousins PM, Peters MG, et al. Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy. J Viral Hepatitis, 2011; 18, 415-23. doi:  10.1111/jvh.2011.18.issue-6
[13] Philipp T, Alexandre M, Margaret R, et al. Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation. P Natl Acad Sci USA, 2015; 112, 5715-24. doi:  10.1073/pnas.1518090112
[14] YingChen, JohnnySze, Ming-LiangHe. HBV cccDNA in patients' sera as an indicator for HBV reactivation and an early signal of liver damage. World J Gastroentero, 2004; 10, 82-5. doi:  10.3748/wjg.v10.i1.82
[15] Singh M, Dicaire A, Wakil AE, et al. Quantitation of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) in the liver of HBV-infected patients by LightCyclerTM real-time PCR. J Virol Methods, 2004; 118, 159-67. doi:  10.1016/j.jviromet.2004.02.006
[16] Loustaud-Ratti V, Wagner A, Carrier P, et al. Distribution of total DNA and cccDNA in serum and PBMCs may reflect the HBV immune status in HBsAg+ and HBsAg-patients coinfected or not with HIV or HCV. Clin Res Hepatol Gas, 2013; 37, 373-83. doi:  10.1016/j.clinre.2012.11.002
[17] Wei JN, Wang SP. Study on the relationship between fetomaternal cellular traffic and hepatitis B virus intrauterine infection. Chin J Epidemiol, 2005; 26, 240.
[18] Shi XH, Wang XF, Xu XX, et al. Impact of HBV replication in peripheral blood mononuclear cell on HBV intrauterine transmission. Front Med, 2017; 11, 548-53. doi:  10.1007/s11684-017-0597-5
[19] Zhang Z, Li AZ, Xiao XM. Risk factors for intrauterine infection with hepatitis B virus. Int J Gynecol Obstet, 2014; 125, 158-61. doi:  10.1016/j.ijgo.2013.10.028
[20] Shao Q, Zhao X, Yao L, et al. Role of peripheral blood mononuclear cell transportation from mother to baby in HBV intrauterine infection. Arch Gynecol Obstet, 2013; 288, 1257-61. doi:  10.1007/s00404-013-2893-x
[21] Peng S, Wan Z, Liu T, et al. Incidence and Risk Factors of Intrauterine Transmission Among Pregnant Women With Chronic Hepatitis B Virus Infection. J Clin Gastroenterol, 2018; 53, 1.
[22] Yu MM, Gu XJ, Xia Y, et al. Relationship between HBV cccDNA expression in the human ovary and vertical transmission of HBV. Epidemiol Infect, 2012; 140, 1454-60. doi:  10.1017/S0950268811002068
[23] Xu M, Zhou Z, Xu R, et al. Antiviral therapy predicts the outcomes following resection of hepatocellular carcinoma in patients negative for HBV DNA:a propensity score matching analysis. World J Surg Oncol, 2019; 17, 45. doi:  10.1186/s12957-019-1577-9
[24] Guo Z, Shi XH, Feng YL, et al. Risk factors of HBV intrauterine transmission among HBsAg-positive pregnant women. J Viral Hepatitis, 2013; 20, 317-21. doi:  10.1111/jvh.2013.20.issue-5
[25] Mavilia MG, Wu GY. Mechanisms and Prevention of Vertical Transmission in Chronic Viral Hepatitis. J Clin Transl Hepatol, 2017; 5, 119-29. doi:  10.14218/JCTH.2016.00067
[26] Zhu YY, Mao YZ, Wu WL, et al. Does hepatitis B virus prenatal transmission result in postnatal immunoprophylaxis failure? Clin Vaccine Immunol, 2010; 17, 1836-41. doi:  10.1128/CVI.00168-10
[27] Han L, Zhang HW, Xie JX, et al. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World J Gastroenterol, 2011; 17, 4321-33. doi:  10.3748/wjg.v17.i38.4321
[28] Guner R, Karahocagil M, Buyukberber M, et al. Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection. Eur J Gastroen Hepat, 2011; 23, 1185. doi:  10.1097/MEG.0b013e32834ba13a
[29] Singla B, Chakraborti A, Sharma BK, et al. Levels of hepatitis B virus replicative intermediate in serum samples of chronic hepatitis B patients. Mol Biol Rep, 2014; 41, 4689-96. doi:  10.1007/s11033-014-3339-7
[30] Ni W, Shi WQ, Tang CL, et al. Correlation of HBV cccDNA content in liver tissue with serum HBV markers and viral load in patients with chronic hepatitis B. Chin J Clin Infect Dis, 2014; 542-3. (In Chinese)
[31] Lu L, Zhang HY, Yueng YH, et al. Intracellular levels of hepatitis B virus DNA and pregenomic RNA in peripheral blood mononuclear cells of chronically infected patients. J Viral Hepatitis, 2009; 16, 104-12. doi:  10.1111/jvh.2009.16.issue-2
[32] Zhu ST, Xie QX, Zhang YF, et al. Detection of the covalently closed [ci]cular DNA in peripheral blood mononuclear cells of hepatitis B patients and its clinical significance. Chin J Infect, 2014; 32, 214-8. (In Chinese)
[33] Seeger C, Mason WS. Molecular biology of hepatitis B virus infection. Virology, 2015; 479-480, 672-86. http://d.old.wanfangdata.com.cn/OAPaper/oai_pubmedcentral.nih.gov_358283
[34] Cui FQ, Bi SL, Zhang Y. Combination Profiles of Hepatitis B Marks for Chinese in Serosurvey in 2006. Chin J Vaccine Immunol, 2009; 15, 294-9. (In Chinese)
[35] Sabrina C, Claudio A, Pierluca P, et al. a statistical model based on serological parameters for predicting occult HBV infection:implications for organ/blood donations. New Microbiol, 2015; 38, 39-49.
[36] Cheng J, Dai Y, Yan L, et al. Clinical Characteristics and Correlation Analysis of Subjects with Chronic Hepatitis B Virus (HBV) Infection and Sustained Low Levels of Hepatitis B Surface Antigen (HBsAg). Med Sci Monit, 2018; 24, 1826-35. doi:  10.12659/MSM.905445
[37] Zhang L, Gui XE, Wang B, et al. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates. BMC Infect Dis, 2016; 16, 408. doi:  10.1186/s12879-016-1754-1
[38] Torii N, Hasegawa K, Joh R, et al. Configuration and replication competence of hepatitis B virus DNA in peripheral blood mononuclear cells from chronic hepatitis B patients and patients who have recovered from acute self-limited hepatitis. Hepatol Res, 2003; 25, 234-43. doi:  10.1016/S1386-6346(02)00275-9